Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-11-06
2007-11-06
Prouty, Rebecca E. (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S213000
Reexamination Certificate
active
10549759
ABSTRACT:
The invention is based on the use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia, comprising the preparation of therapeutic concentrates of alpha-1 antitrypsin, in any form of administration tolerated by humans, the alpha-1 antitrypsin being obtained by purification of human plasma or being produced by recombinant or transgenic technology, with doses equal to or greater than 6 mg of alpha-1 antitrypsin per kg of body weight for a variable period of time.
REFERENCES:
patent: 4440679 (1984-04-01), Fernandes et al.
patent: 6737405 (2004-05-01), Roemisch et al.
Stoller et al., Biochemical Efficacy and Safety of a New Pooled Human Plasma alpha-1 Antitrypsin, Respitin, Chest Journal, 2002, vol. 122, pp. 66-74.
Juvelekian et al., Augmentation Therapy for alpha-1 Antitrypsin Deficiency, Drugs, Aug. 2004, vol. 64, vol. 15, pp. 1743-1756.
Doring et al., Serine Proteinase Inhibitor Therapy in alpha-1 Antitrypsin Inhibitor Deficiency and Cystic Fibrosis, Pediatric Pulmonology, 1999, vol. 28, pp. 363-375.
Blanco et al., “Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency,” J Rheumatology 31(10):2082-2085, Oct. 2004.
Alpha One International Registry (AIR) homepage, http://www.aatregistry.org/, printed on Aug. 18, 2006.
Brantly M.,α1-Antitrypsin: Not Just an Antiprotease; Extending the Half-Life of a Natural Anti-Inflammatory Molecule by Conjugation with Polyethylene Glycol, Am J Respir Cell Mol. Biol. (2002) 27:652-645.
Joaquin Esteve-Vives et al.,The Spanish Version of the Health Assessment Questionnaire: Reliability, Validity and Transcultural EqivalencyJournal of Rheumatology (1993) 20:2116-2112.
Leonard R. Derogatis et al.,The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale, Brit. J. Psychiat. (1976) 128:280-289.
Buchanan & Ingersoll & Rooney PC
Grifols, S.A.
Kosson Rosanne
Prouty Rebecca E.
LandOfFree
Use of Alpha-1 antitrypsin for the preparation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of Alpha-1 antitrypsin for the preparation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of Alpha-1 antitrypsin for the preparation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3818556